(VIANEWS) – Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) rose 5.21% to $240.11 at 13:49 EST on Friday, following the last session’s upward trend. NASDAQ is jumping 1.66% to $13,574.35, following the last session’s downward trend. This seems, as yet, an all-around bullish trend exchanging session today.
Vertex Pharmaceuticals’s last close was $228.22, 6.08% below its 52-week high of $242.99.
Today’s last reported volume for Vertex Pharmaceuticals is 1703171 which is 12.91% below its average volume of 1955856.
The company’s growth estimates for the current quarter and the next is 15.9% and 24.7%, respectively.
Vertex Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth grew by 29%, now sitting on 7.13B for the twelve trailing months.
Vertex Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was 0.02%, 0.21%, and 1.00%, respectively.
Vertex Pharmaceuticals’s highest amplitude of average volatility was 0.70% (last week), 0.76% (last month), and 1.00% (last quarter), respectively.
Vertex Pharmaceuticals’s Stock Yearly Top and Bottom Value
Vertex Pharmaceuticals’s stock is valued at $240.11 at 13:49 EST, under its 52-week high of $242.99 and way above its 52-week low of $176.36.
Vertex Pharmaceuticals’s Moving Average
Vertex Pharmaceuticals’s value is way higher than its 50-day moving average of $184.35 and way higher than its 200-day moving average of $200.51.
More news about Vertex Pharmaceuticals (VRTX).